Lipofuscin, Its Origin, Properties, and Contribution to Retinal Fluorescence As a Potential Biomarker of Oxidative Damage to the Retina
Overview
Authors
Affiliations
Lipofuscin accumulates with age as intracellular fluorescent granules originating from incomplete lysosomal digestion of phagocytosed and autophagocytosed material. The purpose of this review is to provide an update on the current understanding of the role of oxidative stress and/or lysosomal dysfunction in lipofuscin accumulation and its consequences, particularly for retinal pigment epithelium (RPE). Next, the fluorescence of lipofuscin, spectral changes induced by oxidation, and its contribution to retinal fluorescence are discussed. This is followed by reviewing recent developments in fluorescence imaging of the retina and the current evidence on the prognostic value of retinal fluorescence for the progression of age-related macular degeneration (AMD), the major blinding disease affecting elderly people in developed countries. The evidence of lipofuscin oxidation in vivo and the evidence of increased oxidative damage in AMD retina ex vivo lead to the conclusion that imaging of spectral characteristics of lipofuscin fluorescence may serve as a useful biomarker of oxidative damage, which can be helpful in assessing the efficacy of potential antioxidant therapies in retinal degenerations associated with accumulation of lipofuscin and increased oxidative stress. Finally, amendments to currently used fluorescence imaging instruments are suggested to be more sensitive and specific for imaging spectral characteristics of lipofuscin fluorescence.
Ding J, Liu J, Guo Q, Zhang N Antioxidants (Basel). 2025; 14(1).
PMID: 39857369 PMC: 11762529. DOI: 10.3390/antiox14010035.
Abdouh M, Chen Y, Goyeneche A, Burnier M Int J Mol Sci. 2024; 25(23).
PMID: 39684332 PMC: 11641757. DOI: 10.3390/ijms252312619.
Sripunya A, Chittasupho C, Mangmool S, Angerhofer A, Imaram W Bioconjug Chem. 2024; 35(12):1959-1969.
PMID: 39641479 PMC: 11660146. DOI: 10.1021/acs.bioconjchem.4c00475.
Bakker L, Boulton M, Rozanowska M Antioxidants (Basel). 2024; 13(11).
PMID: 39594569 PMC: 11591205. DOI: 10.3390/antiox13111428.
Singh M, Negi R, Alka , Vinayagam R, Kang S, Shukla P Medicina (Kaunas). 2024; 60(10).
PMID: 39459435 PMC: 11509623. DOI: 10.3390/medicina60101647.